3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
2
Completed
2
Active not recruiting
2
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Breast Neoplasms
5
Neoplasm Metastasis
3
Colorectal Neoplasms
3
Biliary Tract Neoplasms
3
Nevi and Melanomas
2
Neoplastic Cells, Circulating
2
Neoplasm, Residual
2
Melanoma
2
Lung Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Recurrence
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neurofibrosarcoma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neoplasms
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Gastrointestinal Stromal Tumors
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Lobular
1
Interventions
pembrolizumab
115
Carboplatin
103
Pemetrexed
90
Cisplatin
58
Paclitaxel
47
osimertinib
41
Drug Therapy
40
Nivolumab
39
Docetaxel
35
Specimen Handling
33
Magnetic Resonance Spectroscopy
28
Bevacizumab
26
durvalumab
23
Gemcitabine
22
cemiplimab
21
Radiotherapy
20
130-nm albumin-bound paclitaxel
20
Radiosurgery
19
tislelizumab
18
atezolizumab
17
aflutinib
15
Cetuximab
15
Immunotherapy
14
Immune Checkpoint Inhibitors
14
Platinum Compounds
13
Ipilimumab
13
Biopsy
12
Standard of Care
11
Surgical Procedures, Operative
10
Injections
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Carcinoma, Non-Small-Cell Lung
×
Liquid Biopsy
×
Clear all
NCT04258137
2025-10-02
COPE
Institut Bergonié
Phase NA
Recruiting
332 enrolled